MTOR and neurofibromatosis type 1: Increased activity in PI3K-AKT-TSC2-mTOR signaling has been implicated in the syndromic forms of autism including tuberous sclerosis, phosphatase and tensin homolog (PTEN)-related disorders, neurofibromatosis type I, and fragile X syndrome.